Efficacy Trial of a DNA/rAd5 HIV-1 Preventive VaccineScott M. Hammer, Peter B. Gilbert, Mark J. Mulligan et al.|New England Journal of Medicine|2013Cited by 586
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly Janes, M. Juliana McElrath, Kristen W. Cohen et al.|The Journal of Infectious Diseases|2017Cited by 75